US Stock MarketDetailed Quotes

RNAC Cartesian Therapeutics

Watchlist
  • 18.160
  • +0.250+1.40%
Trading Nov 29 09:49 ET
461.53MMarket Cap-392P/E (TTM)

Cartesian Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2023/FY
Stock NameRevenueRatio
Research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of26M100.00%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States26M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data